Market Open

LLY
Lilly(Eli) & Co
$ 1,065.64
2.28%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Add to Portfolio
Updated 56 years ago

Lilly(Eli) & Co News

Latest Lilly(Eli) & Co Stock News & LLY Headlines

Focus: Lower cost Novo, Lilly weight-loss pills draw patients from compounded drugs, doctors say
a day ago | reuters.com
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
10 days ago | prnewswire.com
Novo Stock Rises After Earnings. It's Taking the Weight-Loss Drug Fight to Eli Lilly.
16 days ago | barrons.com
Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years
17 days ago | prnewswire.com
Why Eli Lilly Stock Jumped This Week
19 days ago | fool.com
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
22 days ago | prnewswire.com
Eli Lilly investors are eager for Foundayo insight after early launch data
23 days ago | reuters.com
Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So
24 days ago | fool.com
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
25 days ago | prnewswire.com
Eli Lilly (LLY) Declines More Than Market: Some Information for Investors
a month ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 47,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Open

LLY
Lilly(Eli) & Co
$ 1,065.64
2.28%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Add to Portfolio
Updated 56 years ago